期刊文献+

综合性医院特殊使用级抗菌药物临床应用合理性评价 被引量:5

Evaluation of the rationality of clinical application of special use antibacterial drugs in a general hospital
下载PDF
导出
摘要 目的评价中山大学附属江门医院/江门市中心医院住院患者特殊使用级抗菌药物临床应用情况。方法回顾性调查中山大学附属江门医院/江门市中心医院2018年10-12月所有使用特殊级抗菌药物的非儿科患者病历491份,分析限定日剂量数(DDDs)、药物利用指数(DUI),并进行临床用药合理性评价,对不适宜问题进行分类整理。结果注射用美罗培南(0.25 g)的DDDs、DUI最高,分别为1400.38和1.27;总的微生物送检率为85.54%;用药不合理56例次,其中用法用量不适宜(46.43%)和品种选择不适宜(30.36%)为主要问题。结论医院特殊使用级抗菌药物总体应用良好,但也存在一些问题,应继续加强宣传和严格管理,以保护该类药物在治疗严重感染性疾病中的重要地位。 Objective To explore the clinical utilization of antibiotics for special use on patients in Affiliated Jiangmen Hospital of Sun Yat-San University/Jiangmen Central Hospital,analyze and evaluate its medication rationality.Methods A retrospective analysis was made of 491 medical records of all non-pediatric patients using special grade antibacterials in Affiliated Jiangmen Hospital of Sun Yat-San University/Jiangmen Central Hospital from October to December 2018.Defined daily doses(DDDs)and drug utilization index(DUI)were analyzed.The medication rationality of carbapenems was evaluated and inappropriate cases were also classified and analyzed statistically.Results The meropenem for injection(0.25 g)had the highest DDDs and DUIs of 1400.38 and 1.27,respectively.The total rate of microbial inspection was85.54%.There were 56 cases of irrational use records,in which,irrational dosage(46.43%)and improper drug selection(30.36%)were the major problems.Conclusion The antibiotics for special use are generally well applied in the hospital,but there were still some problems.We should continue to strengthen publicity and strict management to protect the important position of this class of drugs in the treatment of serious infectious diseases.
作者 冯志平 于思源 FENG Zhiping;YU Siyuan(Department of Pharmacy,Affiliated Jiangmen Hospital of Sun Yat-San University/Jiangmen Central Hospital,Guangdong Province,Jiangmen 529000,China)
出处 《临床合理用药杂志》 2020年第7期1-2,5,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 特殊使用级 抗菌药物 合理性评价 Special use Antibiotics Rationality analysis
  • 相关文献

参考文献10

二级参考文献78

  • 1刘文静,王瑶,刘勇,赵旺盛,孙自镛,倪语星,孙宏莉,徐英春,谢秀丽,王辉,陈民钧.比阿培南等3种碳青霉烯类抗生素的体外抗菌活性[J].中国感染与化疗杂志,2010,10(6):468-471. 被引量:29
  • 2陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621. 被引量:181
  • 3卓超,黎毅敏,钟南山.卡泊芬净治疗18例肺部真菌感染的临床分析[J].中国抗生素杂志,2007,32(11):689-692. 被引量:12
  • 4Hajjeh RA,Sofair AN,Harrison LH,et al.Incidence of bloodstream surveillance program[J].J Clin Microbiol,2004,42(4):1519-1527. 被引量:1
  • 5Bodro M,SabéN,Gomila A,et al.Risk factors,clinical characteristics,and outcomes of invasive fungal infections in solid organ transplant recipients[M].Transplant Proc,2012,44(9):2682-2685. 被引量:1
  • 6Edmond MB,Wallace SE,Mc Clish DK,et al.Nosocomial bloodstream infections in United States hospitals:a three-year analysis[J].Clin Infect Dis,1999,29(2):239-244. 被引量:1
  • 7Shelton BK.Opportunistic fungal infections in the critically ill[J].Crit Care Nurs Clin North Am,2000,12(3):323-340. 被引量:1
  • 8Ostrosky-Zeichner L,Pappas PG.Invasive candidiasis in the intensive care unit[J].Crit Care Med,2006,34(3):857-63. 被引量:1
  • 9Tortorano AM,Peman J,Bernhardt H,et al.Epidemiology of candidaemia in Europe:results of 28-month European Confederation of Medical Mycology(ECMM)hospital-based surveillance study[J].Eur J Clin Microbiol Infect Dis,2004,23(4):317-322. 被引量:1
  • 10Girois SB,Chapuis F,Decullier E,et al.Adverse effects of antifungal therapies in invasive fungal infections:review and metaanalysis[J].Eur J Clin Microbiol Infect Dis,2006,25(2):138-149. 被引量:1

共引文献125

同被引文献35

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部